Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine‐metabolic disorder associated with insulin resistance (IR). In IR states, non–insulin‐mediated glucose uptake (NIMGU) may increase to compensate for declining insulin‐mediated glucose… Click to show full abstract
Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine‐metabolic disorder associated with insulin resistance (IR). In IR states, non–insulin‐mediated glucose uptake (NIMGU) may increase to compensate for declining insulin‐mediated glucose uptake (IMGU), although this does not appear to be the case in PCOS. The underlying molecular mechanisms for this deficiency remain unclear.
               
Click one of the above tabs to view related content.